Does PALBOCICLIB Cause Dyspnoea? 3,178 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 3,178 reports of Dyspnoea have been filed in association with PALBOCICLIB (Ibrance). This represents 3.5% of all adverse event reports for PALBOCICLIB.
3,178
Reports of Dyspnoea with PALBOCICLIB
3.5%
of all PALBOCICLIB reports
304
Deaths
1,116
Hospitalizations
How Dangerous Is Dyspnoea From PALBOCICLIB?
Of the 3,178 reports, 304 (9.6%) resulted in death, 1,116 (35.1%) required hospitalization, and 65 (2.0%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 3,178 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which PALBOCICLIB Alternatives Have Lower Dyspnoea Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID